Antiemesis.
Ettinger
David S
DS
Bierman
Philip J
PJ
Bradbury
Bob
B
Comish
Carli C
CC
Ellis
Georgiana
G
Ignoffo
Robert J
RJ
Kirkegaard
Steve
S
Kloth
Dwight D
DD
Kris
Mark G
MG
Lim
Dean
D
Markiewicz
Michael Anne
MA
McNulty
Robert
R
Nabati
Lidia
L
Todaro
Barbara
B
Urba
Susan
S
Yowell
Sally
S
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077608:Aprepitant; D019540:Area Under Curve; D002985:Clinical Protocols; D004347:Drug Interactions; D006801:Humans; D008495:Medical Oncology / Q000592:standards; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D064729:Neurokinin-1 Receptor Antagonists; D011878:Radiotherapy / Q000009:adverse effects; D058831:Serotonin 5-HT3 Receptor Antagonists; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control
D000932:Antiemetics; D000970:Antineoplastic Agents; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D058831:Serotonin 5-HT3 Receptor Antagonists; D000077608:Aprepitant